Adda Nathalie's Form 4 filing
Enanta Pharmaceuticals Inc (ENTA) · filed Apr 5, 2022
- Accession no.
- 0001062993-22-009836
- Filed
- Apr 5, 2022
- Trade date
- Apr 1-4, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions and 6 derivative transactions. Open-market sales total $5.97M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Adda NathalieCIK 0001646976 | Officer (Sr. VP & Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Common Stock | MOption exerciseAcquired | +16,000 | $31.42 | +$502,720 | 50,982 | Direct | |
| Apr 1, 2022 | Common Stock | MOption exerciseAcquired | +31,664 | $30.00 | +$949,920 | 82,646 | Direct | |
| Apr 1, 2022 | Common Stock | MOption exerciseAcquired | +2,895 | $48.52 | +$140,465.4 | 85,541 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −8,299 | $70.75 | −$587,154.25 | 77,242 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −42,260 | $71.32 | −$3,013,983.2 | 34,982 | Direct | |
| Apr 4, 2022 | Common Stock | MOption exerciseAcquired | +6,285 | $48.52 | +$304,948.2 | 41,267 | Direct | |
| Apr 4, 2022 | Common Stock | MOption exerciseAcquired | +9,625 | $43.57 | +$419,361.25 | 50,892 | Direct | |
| Apr 4, 2022 | Common Stock | MOption exerciseAcquired | +16,875 | $63.35 | +$1,069,031.25 | 67,767 | Direct | |
| Apr 4, 2022 | Common Stock | SSaleDisposed | −2,500 | $70.56 | −$176,400 | 65,267 | Direct | |
| Apr 4, 2022 | Common Stock | SSaleDisposed | −18,076 | $71.71 | −$1,296,229.96 | 47,191 | Direct | |
| Apr 4, 2022 | Common Stock | SSaleDisposed | −3,200 | $72.65 | −$232,480 | 43,991 | Direct | |
| Apr 4, 2022 | Common Stock | SSaleDisposed | −9,009 | $73.42 | −$661,440.78 | 34,982 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Common Stock | MOption exerciseDisposed | −16,000 | $0.00 | $0 | 0 | Direct | |
| Apr 1, 2022 | Common Stock | MOption exerciseDisposed | −31,664 | $0.00 | $0 | 0 | Direct | |
| Apr 1, 2022 | Common Stock | MOption exerciseDisposed | −2,895 | $0.00 | $0 | 6,285 | Direct | |
| Apr 4, 2022 | Common Stock | MOption exerciseDisposed | −6,285 | $0.00 | $0 | 0 | Direct | |
| Apr 4, 2022 | Common Stock | MOption exerciseDisposed | −9,625 | $0.00 | $0 | 21,175 | Direct | |
| Apr 4, 2022 | Common Stock | MOption exerciseDisposed | −16,875 | $0.00 | $0 | 13,125 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.